Huawei Clarifies Pharma AI Strategy, Phantom Blade Zero Launches, and Google Faces Historic Stock Drop
The October 30 IT morning news roundup covers Huawei's clarification that its pharmaceutical division will focus solely on AI infrastructure rather than drug manufacturing, the strong global Steam launch of the domestic action game 'Phantom Blade Zero', and a historic single-day stock decline for Google Alphabet. These updates highlight major shifts across diverse tech sectors, showing how tech giants are positioning themselves in specialized industrial AI, tracking the commercial prowess of domestic gaming hits, and reflecting market reactions to heavy capital expenditures in artificial intelligence. Huawei's pharmaceutical division president stated the company will not create drugs or pipelines, while 'Phantom Blade Zero' achieved a peak of over 430,000 concurrent players on Steam, and Google Alphabet saw shares drop over 13% amid weaker-than-expected quarterly earnings and aggressive AI spending.
## BACKGROUND
Tech companies increasingly establish specialized B2B divisions to provide cloud computing, data governance, and AI infrastructure to traditional industries like healthcare and pharmaceuticals without competing directly with their clients. Meanwhile, major technology conglomerates face intense scrutiny from investors over whether their massive financial investments in generative artificial intelligence will yield immediate, profitable returns.